Back
Aclaris Therapeutics Vs. Inhibrx(DELISTED) Industry Stock Comparison
Sell
33
ACRS
Aclaris Therapeutics
Last Price:
1.16
Seasonality Move:
-7.32%
Sell
41
INBX:DL
Inhibrx(DELISTED)
Last Price:
30.63
Seasonality Move:
34.15%
Sell
33
Aclaris Therapeutics (ACRS)
is a Sell
Is Aclaris Therapeutics a Buy, Sell or Hold?
- The current Aclaris Therapeutics [ACRS] share price is $1.29. The Score for ACRS is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
- ACRS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
41
Inhibrx(DELISTED) (INBX:DL)
is a Sell
Is Inhibrx(DELISTED) a Buy, Sell or Hold?
- The current Inhibrx(DELISTED) [INBX:DL] share price is $30.63. The Score for INBX:DL is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
- INBX:DL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ACRS Stock Price Chart
What is Aclaris Therapeutics's stock price today?
-
The Aclaris Therapeutics share price today is $1.29
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ACRS is experiencing buying pressure, which is a positive indicator for future bullish movement.
INBX:DL Stock Price Chart
What is Inhibrx(DELISTED)'s stock price today?
-
The Inhibrx(DELISTED) share price today is $30.63
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and INBX:DL is experiencing slight buying pressure.
ACRS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.02 | Buy |
| Relative Strength Index (14 RSI): | 66.06 | Buy |
| Chaikin Money Flow: | 543816 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.04 - 1.2) | Buy |
| Bollinger Bands (100): | (1.11 - 1.27) | Buy |
INBX:DL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.37 | Sell |
| Relative Strength Index (14 RSI): | 18.16 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (33.39 - 34.87) | Sell |
| Bollinger Bands (100): | (33.91 - 37.15) | Sell |
ACRS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.18 | Buy |
| 20-day SMA: | 1.1 | Buy |
| 50-day SMA: | 1.17 | Buy |
| 200-day SMA: | 2.25 | Sell |
| 8-day EMA: | 1.19 | Buy |
| 20-day EMA: | 1.15 | Buy |
| 50-day EMA: | 1.17 | Buy |
| 200-day EMA: | 2.81 | Sell |
INBX:DL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 33.82 | Sell |
| 20-day SMA: | 34.13 | Sell |
| 50-day SMA: | 34.45 | Sell |
| 200-day SMA: | 28.52 | Buy |
| 8-day EMA: | 33.46 | Sell |
| 20-day EMA: | 33.98 | Sell |
| 50-day EMA: | 34.35 | Sell |
| 200-day EMA: | 30.69 | Sell |
Aclaris Therapeutics Earnings Growth & ACRS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.32 per share, an increase next quarter of $0.04 per share, an increase this year of $0.86 per share, and an increase next year of $0.23 per share.
Inhibrx(DELISTED) Earnings Growth & INBX:DL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Aclaris Therapeutics Technical Analysis
| Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Inhibrx(DELISTED) Technical Analysis
| May 28 | May 29 | May 30 | |
|---|---|---|---|
| May | |||
| 28 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | |||
| 8-day SMA: | |||
| 20-day SMA: | |||
| 50-day SMA: | |||
| 200-day SMA: | |||
| 8-day EMA: | |||
| 20-day EMA: | |||
| 50-day EMA: | |||
| 200-day EMA: | |||
| MACD (12, 26): | |||
| Relative Strength Index (14 RSI): | |||
| Bollinger Bands (25): | |||
| Bollinger Bands (100): | |||